In Brief This Week: Ambry Genetics; ArcherDX; EpiCypher; and More | GenomeWeb

NEW YORK (GenomeWeb) — Ambry Genetics announced this week that it has opened a state-of-the-art, 65,000-square-foot "Super Lab" in Aliso Viejo, California. The company said its new fully automated lab is four times larger than any of its other facilities, and will initially process triple the number of patient samples every day, working up to a nine-fold increase over time. Ambry also said it expects to cut turnaround times for genetic tests and panels, improve testing integrity, and increase quality control. It will run 24 hours a day, seven days a week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.